# HEAL-LAA Clinical Trial

> **NCT05809596** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 949 (actual)

## Conditions studied

- Atrial Fibrillation
- Bleeding
- Stroke

## Interventions

- **DEVICE:** WATCHMAN FLX Pro LAAC Device

## Key facts

- **NCT ID:** NCT05809596
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-03
- **Primary completion:** 2024-07-15
- **Final completion:** 2025-09-18
- **Target enrollment:** 949 (ACTUAL)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05809596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05809596, "HEAL-LAA Clinical Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05809596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*